These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24617517)

  • 21. Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?
    Vaucher C; Maillard MH; Froehlich F; Burnand B; Michetti P; Pittet V
    Scand J Gastroenterol; 2016 Sep; 51(9):1056-61. PubMed ID: 26891800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.
    Mañosa M; Navarro-Llavat M; Marín L; Zabana Y; Cabré E; Domènech E
    Scand J Gastroenterol; 2013 Apr; 48(4):427-32. PubMed ID: 23477328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
    Mountifield RE; Prosser R; Bampton P; Muller K; Andrews JM
    J Crohns Colitis; 2010 Jun; 4(2):176-82. PubMed ID: 21122502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change.
    van Langenberg DR; Lange K; Hetzel DJ; Holtmann GJ; Andrews JM
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1250-8. PubMed ID: 20594252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey.
    Haapamäki J; Turunen U; Roine RP; Färkkilä MA; Arkkila PE
    Scand J Gastroenterol; 2008; 43(7):821-30. PubMed ID: 18584521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Compliance to drug therapy in inflammatory bowel diseases outpatients from a university hospital].
    Dewulf Nde L; Monteiro RA; Passos AD; Vieira EM; Troncon LE
    Arq Gastroenterol; 2007; 44(4):289-96. PubMed ID: 18317646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient subjective assessment of drug side effects in inflammatory bowel disease.
    Cross RK; Lapshin O; Finkelstein J
    J Clin Gastroenterol; 2008 Mar; 42(3):244-51. PubMed ID: 18223502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor Documentation of Inflammatory Bowel Disease Quality Measures in Academic, Community, and Private Practice.
    Feuerstein JD; Castillo NE; Siddique SS; Lewandowski JJ; Geissler K; Martinez-Vazquez M; Thukral C; Leffler DA; Cheifetz AS
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):421-428.e2. PubMed ID: 26499928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic sinonasal disease in patients with inflammatory bowel disease.
    Book DT; Smith TL; McNamar JP; Saeian K; Binion DG; Toohill RJ
    Am J Rhinol; 2003; 17(2):87-90. PubMed ID: 12751702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.
    Kane S; Becker B; Harmsen WS; Kurian A; Morisky DE; Zinsmeister AR
    Am J Gastroenterol; 2012 Feb; 107(2):154-60. PubMed ID: 22306937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools.
    Severs M; Zuithoff PN; Mangen MJ; van der Valk ME; Siersema PD; Fidder HH; Oldenburg B
    Inflamm Bowel Dis; 2016 Sep; 22(9):2158-64. PubMed ID: 27482979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication information seeking behavior of patients who use multiple medicines: how does it affect adherence?
    Carter SR; Moles R; White L; Chen TF
    Patient Educ Couns; 2013 Jul; 92(1):74-80. PubMed ID: 23433733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low prevalence of behavioural and emotional problems among Swiss paediatric patients with inflammatory bowel disease.
    Herzog D; Landolt MA; Buehr P; Heyland K; Rogler D; Koller R; Rueger V; Pittet V; Nydegger A; Spalinger J; Schäppi M; Schibli S; Braegger CP;
    Arch Dis Child; 2013 Jan; 98(1):16-9. PubMed ID: 23087189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
    Sokol H; Seksik P; Carrat F; Nion-Larmurier I; Vienne A; Beaugerie L; Cosnes J
    Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.
    Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ
    Gastroenterology; 2007 Dec; 133(6):1779-86. PubMed ID: 18054550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence and quality of care in IBD.
    Bager P; Julsgaard M; Vestergaard T; Christensen LA; Dahlerup JF
    Scand J Gastroenterol; 2016 Nov; 51(11):1326-31. PubMed ID: 27311071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
    Abraham NS; Richardson P; Castillo D; Kane SV
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.